Sandler Capital Management acquired a new stake in shares of Sensient Technologies Corporation (NYSE:SXT - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 78,796 shares of the specialty chemicals company's stock, valued at approximately $5,865,000. Sensient Technologies comprises approximately 1.5% of Sandler Capital Management's portfolio, making the stock its 16th largest holding. Sandler Capital Management owned 0.19% of Sensient Technologies as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Millennium Management LLC lifted its position in Sensient Technologies by 112.1% during the 1st quarter. Millennium Management LLC now owns 115,042 shares of the specialty chemicals company's stock worth $8,563,000 after acquiring an additional 60,807 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Sensient Technologies by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,091 shares of the specialty chemicals company's stock worth $1,868,000 after acquiring an additional 1,107 shares during the period. AQR Capital Management LLC boosted its position in Sensient Technologies by 103.2% during the 1st quarter. AQR Capital Management LLC now owns 8,852 shares of the specialty chemicals company's stock worth $647,000 after acquiring an additional 4,496 shares during the period. Royal Bank of Canada boosted its position in Sensient Technologies by 19.3% during the 1st quarter. Royal Bank of Canada now owns 4,952 shares of the specialty chemicals company's stock worth $369,000 after acquiring an additional 802 shares during the period. Finally, Graham Capital Management L.P. lifted its holdings in shares of Sensient Technologies by 52.6% in the first quarter. Graham Capital Management L.P. now owns 17,798 shares of the specialty chemicals company's stock valued at $1,325,000 after buying an additional 6,135 shares during the period. 90.86% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
SXT has been the subject of several research analyst reports. Robert W. Baird upped their price objective on Sensient Technologies from $93.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, July 3rd. CJS Securities assumed coverage on Sensient Technologies in a research report on Tuesday, June 10th. They set a "market perform" rating and a $95.00 price target on the stock. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Sensient Technologies currently has an average rating of "Moderate Buy" and an average target price of $110.00.
Read Our Latest Stock Analysis on SXT
Sensient Technologies Stock Performance
Shares of SXT stock traded down $2.98 during mid-day trading on Tuesday, reaching $110.24. The stock had a trading volume of 24,068 shares, compared to its average volume of 370,528. The firm's 50 day simple moving average is $112.03 and its 200 day simple moving average is $93.92. The company has a quick ratio of 1.78, a current ratio of 4.25 and a debt-to-equity ratio of 0.61. Sensient Technologies Corporation has a one year low of $66.14 and a one year high of $121.54. The firm has a market cap of $4.68 billion, a PE ratio of 34.78 and a beta of 0.57.
Sensient Technologies (NYSE:SXT - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The specialty chemicals company reported $0.94 EPS for the quarter, topping analysts' consensus estimates of $0.88 by $0.06. Sensient Technologies had a return on equity of 12.56% and a net margin of 8.56%.The company had revenue of $414.23 million during the quarter, compared to the consensus estimate of $417.60 million. During the same quarter last year, the company earned $0.77 EPS. The company's quarterly revenue was up 2.7% on a year-over-year basis. Sensient Technologies has set its FY 2025 guidance at 3.130-3.230 EPS. On average, analysts forecast that Sensient Technologies Corporation will post 3.1 EPS for the current year.
Sensient Technologies Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Monday, August 4th were issued a $0.41 dividend. The ex-dividend date of this dividend was Monday, August 4th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.5%. Sensient Technologies's dividend payout ratio is presently 51.74%.
About Sensient Technologies
(
Free Report)
Sensient Technologies Corporation, together with its subsidiaries, develops, manufactures, and markets colors, flavors, and other specialty ingredients in North America, Europe, Asia, Australia, South America, and Africa. The company offers flavor-delivery systems, and compounded and blended products; ingredient products, such as essential oils, natural and synthetic flavors, and natural extracts; and chili powder, paprika, and chili pepper, as well as dehydrated vegetables comprising parsley, celery, and spinach to the food, beverage, and personal care industries.
Recommended Stories

Before you consider Sensient Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sensient Technologies wasn't on the list.
While Sensient Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.